
Sign up to save your podcasts
Or


Heather Turner, CEO at Carmot Therapeutics, speaks with Venrock partner Nimish Shah to discuss her time as CEO. Turner shares how she guided the company through its acquisition by Roche, advice for other CEOs on the verge of an acquisition, her perspective on the GLP-1 market and what excites her about the future of biotech.
By Venrock, a venture capital firm4.8
6262 ratings
Heather Turner, CEO at Carmot Therapeutics, speaks with Venrock partner Nimish Shah to discuss her time as CEO. Turner shares how she guided the company through its acquisition by Roche, advice for other CEOs on the verge of an acquisition, her perspective on the GLP-1 market and what excites her about the future of biotech.

1,296 Listeners

2,672 Listeners

2,461 Listeners

1,105 Listeners

341 Listeners

337 Listeners

394 Listeners

5,610 Listeners

10,254 Listeners

34 Listeners

551 Listeners

21 Listeners

300 Listeners

475 Listeners

1,480 Listeners